Hi,
This week brought us a lot of ‘healthy’ health-related IPOs with great results. Take a look at the top 5 performers on our Friday weekly debrief.
This was a great week for the biopharma industry, with Vor Biopharma (VOR) taking the spotlight.
The cell therapy company raised $176.9 million with its 9,828,017 shares at $18 apiece, after marketing between $16 and $18. But once the markets opened its shares were valued at $42.02.
This 233% increase from its IPO was its peak, closing at $37.50, still a staggering 108% more than its IPO.
Today another health-related company, had a great opening on Nasdaq. Immunocore Holdings (IMCR), a cancer biotech company sold its 9.9 million shares, raising $258 million.
After ranging between $23 - $25 per share, they priced it at $26 apiece. This was a sign of what was there to come, opening the day trading 156% over its IPO, at $41.
After a calm morning, its priced peek at $51.94 by the afternoon, closing at $43.20. A 66% increase from its IPO.
The innate immune-oncology company Bolt Biotherapeutics (BOLT), went public today on Nasdaq, raising $230 million from its upsized IPO.
After targeting its shares between $16 - $18 per share, they priced their 11.5 million shares at $20 apiece. Once the markets opened it was being traded at $26.10 - 131% over its IPO.
As the day moved forward, so did their shares price, peaking at $33.96 by the afternoon, closing at $32.15. A 60.75% increase over its IPO.
Sana Biotechnology (SANA)the cutting-edge gene engineering company went public yesterday on Nasdaq, raising up to $150 million with its 23.5 million shares.
Priced at $25 per share, exceeding the price target range set earlier at $23 to $24 per share, it opened at $37.90. After peaking at $38.45, it managed to call it a day at $35.10, a 140% increase over its initial price.
As of today, they continued their great performance, closing over 56,58% of its IPO, at $39.12.
Lucira Health (LHDX), which is developing single-use test kits for COVID-19 and other infectious diseases, raised $153 million, with its 9 million shares.
After ranging between $15 to $17 per share, they priced it at $17. This value went up 130% to $22.10 apiece once Nasdaq opened.
After a stable day on the market, it closed the week at $24.98, 46.94% over its IPO.
Have a nice weekend and we'll be back next week for more fresh IPOs!
Would you like to get an IPO Brief every Monday with first hand insights on upcoming IPOs and get a personal notification when each stock goes public? Subscribe here.